Mitochondrial Medicine at Children’s Hospital of Philadelphia (CHOP) is emerging as the premiere center in the world for multidisciplinary clinical care, advanced diagnostics and therapies, and individualized basic, translational, and clinical research programs dedicated to improving the health of patients of all ages living with mitochondrial disease. The program is part of the Division of Human Genetics.
Mitochondrial Medicine is designated a Frontier Program by CHOP. Frontier Programs are unique, cutting-edge programs that will forge important new discoveries, deliver novel therapies, and help even more children and adults thrive.
To reduce the spread of COVID-19, Mitochondrial Medicine is actively working to expand the use of video visits and other telehealth options as an alternative to in-person visits when clinically safe and appropriate.
You will have access to the nation’s top pediatric specialists across the many clinical areas that may be part of your or your child’s care. We embrace a coordinated, multidisciplinary approach to support your family.
Diagnostic Testing at CHOP
Integrated diagnostic tests developed at CHOP can provide definitive diagnosis, leading to better treatments. New discoveries are happening every day to create additional methods to diagnose mitochondrial disease.
Conditions We Treat
Our dedicated team members are focused on determining the best course of treatment for each patient while working in collaboration with your primary care physician, neurologist, and other specialists.